logo

For the Inventor, By the Inventor

Garches, France

Pierre Braquet

USPTO Granted Patents = 24


Average Co-Inventor Count = 2.6

ph-index = 8

Forward Citations = 162(Granted Patents)


Company Filing History:

goldMedal19 out of 73 
 
Societe De Conseils De Recherches Et D'applications Scientifiques
 patents
silverMedal2 out of 525 
 
Ludwig Institute for Cancer Research Limited
 patents
bronzeMedal2 out of 119 
 
Societe De Conseils De Recherches Et D'applications Scientifiques (s.c.r.a.s.)
 patents
4. 1 out of 1 
 
Department D'immunologie Institut Henri Beaufour
 patent
5. 1 out of 1 
 
Departemente D'immunologie Institut Henri Beaufour
 patent
6. 1 out of 1 
 
Societe De Conseils De Recherches Et D'application (s.c.r.a.s.)
 patent
where one patent can have more than one assignee

Years Active: 1988-1999

Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents
1. 5906993 - Treating disorders characterized by excessive cell proliferation with (1999-05-25),
2. 5492906 - Derivatives of thieno-triazolo-diazepine and therapeutic compositions (1996-02-20),
3. 5480999 - Dual inhibitors of NO synthase and cyclooxygenase, therapeutical (1996-01-02),
4. 5447942 - N-derivatives of (phenylethyl-.beta.-ol) amine, a process for their (1995-09-05),
5. 5360925 - Dual inhibitors of no synthase and cyclooxygenase, process for their (1994-11-01),
6. 5246701 - Method for inhibiting production of IgE by using IL-9 inhibitors (1993-09-21),
7. 5168098 - Pyrrolo-pyridine derivatives and therapeutic compositions containing them (1992-12-01),
8. 5147856 - Method for inhibiting blood vessel blockage using octapeptide (1992-09-15),
9. 5132109 - Method for inhibiting production of IGE and method for enhancing (1992-07-21),
10. 5118674 - 3-(N-methyl-N-alkyl)-amino 2-methoxymethylene propan 1-ol derivatives, a (1992-06-02),
11. 5116992 - Glycerol derivatives, and therapeutical compositions containing them (1992-05-26),
12. 5081148 - Blocking agents of EDRF effect or formation for the treatment of shock (1992-01-14),
13. 5075322 - Selenophen derivatives, a preparation process of the same and (1991-12-24),
14. 5049560 - Sulfonyl derivatives of thieno-triazolo-diazepines useful as anti-PAF (1991-09-17),
15. 5049559 - Thieno-triazolo-diazepine derivatives useful as anti-ischemic agents (1991-09-17),

Title: Pierre Braquet: Innovator in Cell Proliferation Therapeutics

Introduction

Pierre Braquet is a prominent inventor based in Garches, France, known for his significant contributions to the field of therapeutics. With an impressive portfolio of 24 patents, Braquet has focused extensively on innovations that address various health disorders.

Latest Patents

Among his latest innovations, Braquet developed a series of compounds for treating disorders characterized by excessive cell proliferation. One notable patent involves derivatives of thieno-triazolo-diazepine and therapeutic compositions. This inventive work relates to thieno-triazolo-diazepine derivatives represented by a specific formula, where Y can be oxygen or sulphur, and R signifies a range of substituents. These compounds have shown promise as anti-asthmatic, anti-allergic, and gastrointestinal protectors, demonstrating tremendous potential for therapeutic applications.

Career Highlights

Throughout his career, Pierre Braquet has held key positions in notable organizations. He notably worked with the Société de Conseils de Recherches et D'applications Scientifiques, contributing to the organization's research initiatives. Additionally, Braquet was associated with the Ludwig Institute for Cancer Research Limited, which provided a platform for advancing his inventiveness in biomedical research.

Collaborations

Braquet's research journey includes collaborations with esteemed colleagues like Colette Broquet and Andre Esanu. These partnerships have further enriched his work, leading to significant advancements in understanding and treating various medical conditions.

Conclusion

Pierre Braquet's contributions as an inventor reflect a deep commitment to innovating therapeutic solutions for challenging health issues. His extensive patent portfolio and collaborative efforts highlight his role in advancing medical research and improving patient outcomes. As innovations continue to emerge from his work, Braquet remains a pivotal figure in the quest for effective treatments against cell proliferation disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…